851 related articles for article (PubMed ID: 12381217)
1. Therapeutic drug monitoring in the treatment of tuberculosis.
Peloquin CA
Drugs; 2002; 62(15):2169-83. PubMed ID: 12381217
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic drug monitoring in the treatment of tuberculosis: an update.
Alsultan A; Peloquin CA
Drugs; 2014 Jun; 74(8):839-54. PubMed ID: 24846578
[TBL] [Abstract][Full Text] [Related]
3. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
API Consensus Expert Committee
J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
[TBL] [Abstract][Full Text] [Related]
4. Optimizing treatment outcome of first-line anti-tuberculosis drugs: the role of therapeutic drug monitoring.
Verbeeck RK; Günther G; Kibuule D; Hunter C; Rennie TW
Eur J Clin Pharmacol; 2016 Aug; 72(8):905-16. PubMed ID: 27305904
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic Accuracy of Therapeutic Drug Monitoring During Tuberculosis Treatment.
Anderson G; Vinnard C
J Clin Pharmacol; 2022 Oct; 62(10):1206-1214. PubMed ID: 35588142
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and Drug-Drug Interactions of Lopinavir-Ritonavir Administered with First- and Second-Line Antituberculosis Drugs in HIV-Infected Children Treated for Multidrug-Resistant Tuberculosis.
van der Laan LE; Garcia-Prats AJ; Schaaf HS; Tikiso T; Wiesner L; de Kock M; Winckler J; Norman J; McIlleron H; Denti P; Hesseling AC
Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29133558
[TBL] [Abstract][Full Text] [Related]
7. Cure of tuberculosis despite serum concentrations of antituberculosis drugs below published reference ranges.
Meloni M; Corti N; Müller D; Henning L; Gutteck U; von Braun A; Weber R; Fehr J
Swiss Med Wkly; 2015; 145():w14223. PubMed ID: 26700218
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of isoniazid, rifampicin, pyrazinamide and ethambutol in HIV-infected Indian children.
Mukherjee A; Velpandian T; Singla M; Kanhiya K; Kabra SK; Lodha R
Int J Tuberc Lung Dis; 2016 May; 20(5):666-72. PubMed ID: 27084822
[TBL] [Abstract][Full Text] [Related]
9. Low antituberculosis drug concentrations in patients with AIDS.
Peloquin CA; Nitta AT; Burman WJ; Brudney KF; Miranda-Massari JR; McGuinness ME; Berning SE; Gerena GT
Ann Pharmacother; 1996 Sep; 30(9):919-25. PubMed ID: 8876848
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic drug monitoring in the treatment of tuberculosis patients.
Magis-Escurra C; van den Boogaard J; Ijdema D; Boeree M; Aarnoutse R
Pulm Pharmacol Ther; 2012 Feb; 25(1):83-6. PubMed ID: 22179055
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of the First-Line Antituberculosis Drugs in Ghanaian Children with Tuberculosis with or without HIV Coinfection.
Antwi S; Yang H; Enimil A; Sarfo AM; Gillani FS; Ansong D; Dompreh A; Orstin A; Opoku T; Bosomtwe D; Wiesner L; Norman J; Peloquin CA; Kwara A
Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27855070
[TBL] [Abstract][Full Text] [Related]
12. The Role of Therapeutic Drug Monitoring in Mycobacterial Infections.
Peloquin C
Microbiol Spectr; 2017 Jan; 5(1):. PubMed ID: 28084209
[TBL] [Abstract][Full Text] [Related]
13. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
[TBL] [Abstract][Full Text] [Related]
14. Standard therapy for tuberculosis 1985.
Snider DE; Cohn DL; Davidson PT; Hershfield ES; Smith MH; Sutton FD
Chest; 1985 Feb; 87(2 Suppl):117S-124S. PubMed ID: 3881230
[TBL] [Abstract][Full Text] [Related]
15. The management of tuberculosis: epidemiology, resistance and monitoring.
Bang D
Dan Med Bull; 2010 Nov; 57(11):B4213. PubMed ID: 21055374
[TBL] [Abstract][Full Text] [Related]
16. Provisional CDC guidelines for the use and safety monitoring of bedaquiline fumarate (Sirturo) for the treatment of multidrug-resistant tuberculosis.
Centers for Disease Control and Prevention
MMWR Recomm Rep; 2013 Oct; 62(RR-09):1-12. PubMed ID: 24157696
[TBL] [Abstract][Full Text] [Related]
17. Prevention and treatment of tuberculosis among patients infected with human immunodeficiency virus: principles of therapy and revised recommendations. Centers for Disease Control and Prevention.
MMWR Recomm Rep; 1998 Oct; 47(RR-20):1-58. PubMed ID: 9809743
[TBL] [Abstract][Full Text] [Related]
18. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic drug monitoring of antimycobacterial drugs in patients with both tuberculosis and advanced human immunodeficiency virus infection.
Holland DP; Hamilton CD; Weintrob AC; Engemann JJ; Fortenberry ER; Peloquin CA; Stout JE
Pharmacotherapy; 2009 May; 29(5):503-10. PubMed ID: 19397460
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic drug monitoring in the treatment of active tuberculosis.
Babalik A; Babalik A; Mannix S; Francis D; Menzies D
Can Respir J; 2011; 18(4):225-9. PubMed ID: 22059181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
